Partnership Links Flow Cytometry Instruments and Reagents

The "C6 System” includes blue and red lasers, four color detectors and both forward and side scatter detectors plus software that the manufacturer says is so intuitive that customers typically have the instrument up and running within an hour of receiving it.

The other half of the partnership is eBioscience (San Diego, CA, USA) a privately held company that makes more than 11,000 innovative high quality cell analysis reagents. Their product list comprises an array of high performing solutions, such as fluorescent dyes and bead assay reagents that enable comprehensive analysis of cells and soluble factors in the areas of immunology and cell biology research.

The partnership is designed to offer researchers a better and more comprehensive solution for their flow cytometry needs, harnessing the cost-effectiveness, ease-of-use, performance capabilities, and accessibility of the Accuri C6 Flow Cytometer System with the market leading extensive line of high quality cytometer research reagents offered by eBioscience.

"We are pleased to partner with reagent leader eBioscience to offer our growing customer base a wide range of quality reagents optimized for their varied research needs,” said Jack Ball, chief commercial officer of Accuri. "The adoption of the Accuri C6 Flow Cytometer System by over 500 research labs for an increasing range of applications has brought the need for high quality reagents that work seamlessly with our systems to the fore. This marketing partnership allows Accuri to further deliver on our promise to our customers to offer an affordable, easy-to-use flow cytometer solution—now made even more accessible with the easy availability of a full range of quality research reagents.”

"We are delighted to partner with Accuri, the fastest growing supplier of flow cytometers, and welcome the opportunity to educate our customers about the advantages of having a flow cytometer in their research labs, along with the outstanding performance attributes and surprising accessibility of the Accuri C6 Flow Cytometer system,” said Tony Ward, vice president of commercial operations of eBioscience. "As part of our shared goal to make high performance cell analysis more accessible to researchers worldwide, this agreement will provide customers with an effective and comprehensive solution right out of the box.”

Related Links:
Accuri Cytometers
eBioscience